3M Co Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $25.2B+2.5% YoYTTM through 30 Jun 2026
Net Income $3B-28.2% YoYTTM through 30 Jun 2026
Free Cash Flow $4BTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| EBITDA Margin | 23.9% |
| Operating Margin | 18.4% |
| Net Margin | 11.9% |
Returns
101.5%ROE
8.6%ROA
23.8%ROIC
Balance Sheet Health
Debt / Equity4.26x
Current Ratio1.24x
Net Debt$9.6B
Cash & Equivalents$3B
Quality Metrics
Altman Z-Score4.44
Piotroski F-Score5 / 9
FCF Margin15.8%
Rule of 4016.7
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $24.9B
Diluted EPS$5.63TTMFY2025: $6.00
Dividend
$1.56Per share, FY20260.92%Yield-20.6%5-yr growth
Capital Allocation
R&D Spend$700M
Capex Intensity3.6%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.